Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 281 |
TVIS42001632
|
Epstein-Barr Virus |
- |
NC_007605 |
116239 |
- |
hg38 |
chrX |
42927763 |
42927763 |
p11.3 |
ENSG00000301130 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 282 |
TVIS42001633
|
Epstein-Barr Virus |
- |
NC_007605 |
78609 |
- |
hg38 |
chr2 |
63043330 |
63043330 |
p15 |
EHBP1-AS1, EHBP1 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 283 |
TVIS42001634
|
Epstein-Barr Virus |
- |
NC_007605 |
113685 |
- |
hg38 |
chr3 |
166362415 |
166362415 |
q26.1 |
- |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 284 |
TVIS42001635
|
Epstein-Barr Virus |
- |
NC_007605 |
111569 |
- |
hg38 |
chr18 |
49192590 |
49192590 |
q21.1 |
DYM |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 285 |
TVIS42001636
|
Epstein-Barr Virus |
- |
NC_009334 |
64639 |
- |
hg38 |
chr4 |
188392655 |
188392655 |
q35.2 |
ENSG00000304922 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 286 |
TVIS42001637
|
Epstein-Barr Virus |
- |
NC_007605 |
11565 |
- |
hg38 |
chr7 |
42218914 |
42218914 |
p14.1 |
GLI3 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 287 |
TVIS42001638
|
Epstein-Barr Virus |
- |
NC_007605 |
124398 |
- |
hg38 |
chr2 |
155301933 |
155301933 |
q24.1 |
- |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 288 |
TVIS42001639
|
Epstein-Barr Virus |
- |
NC_007605 |
66672 |
- |
hg38 |
chr3 |
149277639 |
149277639 |
q25.1 |
ENSG00000293384 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 289 |
TVIS42001640
|
Epstein-Barr Virus |
- |
NC_007605 |
69913 |
- |
hg38 |
chr9 |
23444975 |
23444975 |
p21.3 |
- |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 290 |
TVIS42001641
|
Epstein-Barr Virus |
- |
NC_007605 |
86923 |
- |
hg38 |
chr2 |
238726208 |
238726208 |
q37.3 |
LINC01937 |
Tumor |
Multiple |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |